Flexible support for biologics development, drug characterization, and clinical lab services—because no two projects are alike
01
Area of expertise
From concept to clinic, we deliver broad biologics development services through integrated workflows or standalone solutions. Whether you need end-to-end support or targeted expertise, our team ensures optimal outcomes at every stage of your biopharmaceutical journey.
02
Area of expertise
Our comprehensive analytical services adapt to your biologic's structure, modality, and development phase. From feasibility studies to regulatory submissions, we function as your extended team, delivering scientifically rigorous, well-documented results with clarity and speed.
03
Your clinical trial success depends on accurate, reliable bioanalytical data. We provide inclusive bioanalysis of clinical samples in our GCLP-compliant, ISO 9001-certified laboratories, following ICH, FDA, and EMA guidelines for regulatory confidence.
What We Deliver
Erica Kerkvliet, VP R&D
Pharming Group N.V.
“FyoniBios’ versatile cell line platforms and expertise in glycobiology were instrumental in testing our complex product candidates. Their support enabled us to make informed decisions with confidence. Highly recommended!”
Pierre Dönnes, Co-founder & VP Neoantigen Discovery
Strike Pharma AB
“We’ve been highly impressed with FyoniBio’s cell line and process development services. The team consistently delivers quality results on time, with excellent communication making the process seamless and efficient.”
Paulina Dabrowska-Schlepp, Director CMC-QC & Nonclinical Development
eleva
“Working with FyoniBio’s Clinical Bioanalysis group to develop and validate an ADA assay for Eleva was an exceptionally positive experience. When the standard approach proved ineffective, their expertise and innovative thinking led to a new assay format that met our requirements and guidelines. Their dedication and high-quality results were evident throughout. We’re highly satisfied and look forward to the clinical sample analysis phase.”
Philippe Ulsemer, Co-founder and CEO
Acaryon GmbH
“FyoniBio has been a solid and trustworthy partner in mass spectrometry-based analytics. Over the course of several years, the company has established a method for quantifying short-chain fatty acids in cell culture supernatants using ultra-performance liquid chromatography–mass spectrometry. Working with FyoniBio has been a real advantage, and we look forward to more successful projects together. “
Ricarda Finnern, Chief Scientific Office
LenioBio GmbH
“It is a real pleasure to work with the analytical team at FyoniBio! Always in time and even with more complicated Mass Spec analysis the results are displayed and explained in an easy to understand way even for complicated things. Absolutely worth it!”
Science isn’t static — and neither are we.
You’ll find us at key biotech and pharma events around the world, meeting researchers, exploring new ideas, and talking shop about real-life challenges in biologics development.
Got a project in mind? Stop by our booth, grab a coffee, and let’s talk.
Let's discuss how our integrated approach can support your biopharma journey.
